Doseology Sciences Inc.
Research Doseology Sciences Inc. (VU70) on Bullrun: market cap EUR 1.21M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVU70
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 1.21M
- Financial periodQ4 2025
- RevenueEUR 49.22K
- Net income-EUR 339.32K
- Free cash flow-EUR 662.03K
- Gross margin34.2%
Valuation Snapshot
latest market cap is EUR 1.21M.
About Doseology Sciences Inc.
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc.
Frequently asked questions
What is Doseology Sciences Inc.'s market cap?
Doseology Sciences Inc.'s market capitalization is EUR 1.21M.
What does Doseology Sciences Inc. do?
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures.